We present a novel type of injectable biomaterial with an elastic softening transition.
situ shaping and unprecedented dynamic matching of adipose tissue mechanics. In vivo, predetermined shapes can be sculpted manually after subcutaneous injection in mice.
The 3D shape is maintained during excellent host tissue integration into the particle pore space. The meta-biomaterial sustains vascularized connective tissue to the end of one-year follow-up.
Aging, disease, trauma, congenital deformities and surgical sequelae can all lead to a loss or lack of soft tissue volume, producing a major and increasing medical demand for tissue reconstruction strategies [1] [2] [3] [4] . Ideally, such procedures should be minimally invasive to reduce the patient burden and decrease potential surgical complications 5, 6 .
For soft tissue reconstruction, this requires a tissue bulking agent that can be injected through a thin needle into a target site in the body 4 . However, after deployment this bulking material must maintain a stable three-dimensional (3D) configuration to provide adequate volume for the missing soft tissue 7 . Beyond injectability and volume maintenance, surgeons impose the additional requirement of in situ shapeability in order to smoothly match the arbitrary geometry of a patient's tissue defect 8 . Even if the three conditions of injectability, shapeability and stability are satisfied, this theoretical tri-state material should also exhibit a high degree of biocompatibility while closely matching the local tissue mechanics 9, 10 .
In practice, such an ideal material is exceedingly difficult to engineer. For example, fluidlike behavior needed for minimally-invasive delivery through a needle limits mechanical stiffness 11 . As a result, many of the currently available injectable agents are too soft 11 to match the local tissue properties 12, 13 . Though useful for smoothing and enhancing existing shapes, they require improvements to adequately lift and shape threedimensional tissue volumes 11 . On the other hand, solid-like behavior in preformed implants interferes with in-situ shaping, even if minimally invasive delivery is possible by compression or folding 14, 15 . This unmet need has launched numerous efforts to engineer injectable, shape-fixable tissue implants, based on various physical or chemical in-situ crosslinking mechanisms 16, 17 . Emerging strategies include the use of peptide, DNA, or polyelectrolyte and other complexes to impart intrinsic self-healing ability [18] [19] [20] .
Though such approaches provide improved mechanical properties, they also impose a number of additional chemical constraints and raise concerns regarding biocompatibility and tissue integration 16, 21, 22 .
Here, we reconcile injectability, shapeability, and long-term volume stability by a radically novel approach: an injectable meta-material 23 . Mechanical meta-materials obtain unusual properties by their mere geometry 23, 24 . We hypothesize here that physical interlocking of geometrically designed particles can restore meta-material properties even after transient liquefaction for injection [25] [26] [27] . In this novel paradigm, self-healing delivers meta-material physics in-vivo, in-situ, in a minimally invasive fashion. We engineer a tri-state microgel meta-biomaterial that combines injectability, solid-state softening for shapeability, and tissue-mimicking mechanical stability 12, 13 . The material dramatically increases the accessible stiffness range and for the first time demonstrates a reversible elastic softening transition in an injectable. It exhibits excellent biocompatibility and is colonized to induce formation of vascularized tissue.
Taken together, we have successfully integrated the design criteria informed by clinical need to engineer a novel injectable and shapeable biomaterial for stable 3D soft tissue reconstruction.
Results
Elastic porous injectable (EPI) biomaterial The concept of our elastic, porous, and injectable (EPI) biomaterial is illustrated in Figure 1 . Under the high shear imposed by injection, the material fluidizes and behaves as a liquid (Fig. 1a ). Under intermediate shear, typical of in situ shaping and massaging 8, 28 , the EPI biomaterial behaves as a weak viscoelastic solid amenable to smooth deformation ( Fig. 1b ). At rest, the self-healing process is complete and the EPI biomaterial behaves as a soft solid with shear moduli in the lower kPa range to match the native tissue properties 12, 13 (Fig. 1c ).
The EPI biomaterial consists of an interlocking suspension of highly irregular, spongelike microparticles. Its unique material design enables both fluidic injection through a cannula and shapeable three-dimensional stability. A macroscopic demonstration of the behavior is provided in Fig. 1d , while Fig. 1e shows the irregular, porous particle morphology. Fig. 1f and 1g demonstrate microsopic particle interlocking.
In-silico design
To design the EPI biomaterial, outlined in Fig. 1 , we first performed a discrete element simulation. This essential step translates the clinical use criteria into a set of design rules that guided our material fabrication strategy. To reiterate, an ideal tissue-filling biomaterial should display injectability, shapeability, 3D volume stability, biocompatibility, and tissue-matching mechanical properties.
Fig. 2. In Silico simulation and design of the EPI biomaterial. a) Graphical overview of the simulation. b) Elastic storage and viscous loss modulus (G' and G'') for a dense
suspension of frictional spheres c) for a bulk material formed by full cross-linking of every neighboring sphere d) for a dense suspension of discrete, compact, irregular particles formed from neighboring spheres e) for a dense suspension of discrete, irregular particles with a low crosslink density and free contact interfaces. f) Characteristic rheological response with accompanying storage modulus and strain values. = low-deformation limit, = softening transition, = soft plateau stress, = yield strain. 25 . To meet the long-standing challenge of symmetrical stress tensor evaluation in granular media 29, 30 , we systematically reviewed and corrected the published mathematical framework 25 and stress tensor evaluation 29 (Supplementary 1). We then added permanent crosslinks to study both irregular and porous microparticles ( Fig. 2a ).
Analogous to the empirical characterization of viscoelastic agents for soft tissue reconstruction 8 , we performed in silico oscillatory shear rheometry by application of time-varying strain( Fig. 2a ). This provides an estimate of the elastic stiffness (elastic storage modulus G') and the ability to deform (viscous loss moduli G'') 25, 31 .
We first simulated four prototypical scenarios of microgel suspensions: a simple suspension of frictional spherical microgels ( Fig. 2b , Supplementary video 18), completely crosslinked elastic bulk material ( Fig. 2c , Supplementary video 19), compactly crosslinked irregular particles ( Fig. 2d , Supplementary video 20) and loosely crosslinked particles with a decreased internal crosslinking density ( Fig. 2e ;
Supplementary video 21). An elastic softening transition was found for the frictional spherical microgel suspension as expected 25 (Fig. 2b , absent in non-frictional control provided in Supplementary 5 ). But the yield strain was substantially below the 50% typically required for a soft tissue filler 8 to withstand physiological movement 32 . On the other hand, bulk crosslinking ( Fig. 2c ) abolished the yielding transition altogether.
Irregular particles finally ( Fig. 2d ) exhibited yield strain well above 50%, enabling both injectability and in vivo shape stability. This establishes our first design rule: The material should be a suspension of irregular rather than spherical particles.
Quantitatively, the elastic softening transition was better preserved in loosely (vs. densely) crosslinked particles ( Fig. 2e ). The softening behavior is critical both for shapeability and for matching the mechanical properties of local adipose tissue, which also demonstrate strain softening under shear 12, 13 . We thus obtain our second design rule: the particles should have a low density of internal crosslinks with frictional intraparticle porosity.
With our first two design rules established, we generalized the desired rheological behavior ( Fig. 2f ) and performed systematic analysis of the model's parameters ( Fig. 2g , Supplementary 5 ). The analysis confirmed that the geometric parameters (particle shape and porosity) dominate the high-strain behaviors 33 of yielding ( in Fig. 2f and 2g) and the soft plateau ( ), important for shaping and injection. Conversely, the mechanical parameters (friction, packing, and Young's modulus) dominate the lowstrain behaviors of softening ( ) and the low-strain plateau shear modulus ( ), important for tissue interaction.
Specifically, Fig. 2h indicates that the low-strain storage modulus was proportional to the Young's modulus of the constituent microgel material (linear regression, P=8*10 -88 ), but independent of the particle geometry (P=0.50) or crosslinking density (P=0.29) (statistical analysis in Supplementary 14, item 27). Ideally, our material's low-strain mechanical behavior would match that of native soft tissue (lower kPa range 12, 13 ). Thus we obtain our third design rule: the bulk precursor from which we synthesize our microparticle suspension should have a storage modulus close to the low strain limit of adipose tissue.
The first three design criteria produce the optimal rheology for injectability, shapeability, and tissue-matching 3D stability. Our last guideline comes from the established rule that scaffolds should have pores of at least 50 µm diameter to ensure vascularization and colonization 34, 35 . Thus we obtain our fourth and final design rule:
the microparticles should have a mean pore size of at least 50 microns.
Synthesis and mechanical characterization
Our in silico analysis revealed that an injectable, shapeable, and volume-stable material could be achieved by a densely packed suspension of elastic, frictional microparticles with irregular porous geometry ( Fig. 2 ). To further ensure biocompatibility we based our synthesis on the cryogelation 36 of carboxymethylcellulose 34, 37 . The polymer content was adjusted to obtain a porous bulk material with an elastic storage modulus (G') of 2.4kPa +/-0.9kPa (Supplementary 6). We therefore satisfied design rule #3, which stated that the bulk precursor elastic storage modulus should be in the low-strain limit of adipose tissue 12, 13 . Through forceful extrusion we then fragmented the highly porous bulk material 37 into irregular microparticles with a diameter of 805 +/-363 µm (Supplementary 7). Thanks to the intra-particle porosity, the pore space in the resulting EPI biomaterial displays an intricate and widely connected morphology ( Fig. 3a ). This unique porosity contrasts starkly with that of a traditional microgel suspension like the chromatography medium Sephacryl S200 38 , where pores are limited to the interstices between the dense spherical particles ( Fig. 3b ). Therefore the abundance of large frictional pore spaces fulfilled design rules #2 and #4, while the exceptional irregularity fulfilled design rule #1. Thus we obtained an elastic, porous, and injectable (EPI) biomaterial that satisfied our predefined design criteria.
With the fabrication phase complete we began extensive physical characterization. We first investigated the presence of an elastic softening transition, along with high yield strain, as predicted by our simulation (Fig. 2 ). For this, we subjected the EPI biomaterial (at various levels of polymer concentration) to increasing oscillatory shear stress ( Fig.   3c , Supplementary 10). We indeed observed a stable elastic plateau, a unique softening transition, and yielding at high strain (62 +/-5%) for a wide range of polymer concentrations, Supplementary 10 ). Normalization to the low-strain plateau value (G0') 39 confirms that these features are conserved for the EPI biomaterial across all tested concentrations ( Fig. 3d ). As expected for an essentially non-frictional 33 Our next aim was precise mechanical matching to adipose tissue 12, 13 , while conserving a pore size greater than 50μm required for vascularization 34, 35 . Fig. 3e demonstrates indeed an inverse relation between G0' and the average pore diameter: Fluid withdrawal to increase polymer concentrations lowered both total pore fraction and average pore size (Supplementary 8). With the EPI biomaterial, adipose tissue stiffness G0'=2-3kPa 12, 13 was matched while successfully maintaining a pore size of 100-120 µm ( Fig.   3e , Supplementary 8 and 9). On the contrary, sufficient stiffness in the Sephacryl S200 material could only be achieved at insufficient pore size, and vice versa. The EPI biomaterial design thus specifically enables the joint fulfillment of both mechanical and geometric requirements.
We further assessed dynamic adipose tissue matching by rheological comparison of the EPI biomaterial to the published rheological response of adipose tissue (bovine, retroorbital 13 ). We find that the EPI biomaterial dynamically mimicks the overall adipose tissue response over a wide range of deformations ( Fig. 3f ). In addition, the EPI biomaterial shows yielding behavior similar to the established dermal filler Juvéderm Voluma (Fig. 3f ). The Juvéderm Voluma filler is known to consist of irregularly shaped microparticles 40 , confirming the predicted importance of this feature for high yield strain (57+/-7 % for Juvéderm Voluma®, P=1.0 vs. EPI biomaterial, Supplementary 10 ).
The softening transition engineered into the EPI biomaterial additionally offers the unprecedented dynamic tissue matching.
For minimally invasive delivery, the EPI biomaterial must be injectable. Supplementary 14 ). This increase was likely due to dehydration during transfer steps. Overall, we conclude that the EPI biomaterial can easily be injected and retains its mechanical properties after minimally invasive delivery through a cannula.
Finally, we investigated the physical self-healing process enabling restoration of solidlike mechanical integrity after the injection process. For Fig. 3j , self-healing of the EPI biomaterial following fluidization was assessed under weak (0.1Pa) to strong (50 Pa) continuous oscillatory stress. Self-healing was efficient for all stress levels, but different time-scales were involved. For smaller shear stresses, substantially higher G' values were eventually achieved, but the final value was reached on a time scale of 10 minutes or above ( Fig. 3j, Fig. 3k, Supplementary 12 ). For strong continuous shear stress, relatively low but stable G' values were rapidly established. Using an abrupt switch of stress slightly above and below yield stress, we could indeed demonstrate nearinstantaneous recovery (Fig. 3i , additional creep-recovery data in Supplementary 13 ).
We believe that the immediate self-healing after injection could stabilize the injected implant to prevent unwanted spreading, followed by attainment of a much higher elastic storage modulus to better match the local adipose tissue at longer time scales.
In summary, we have engineered an elastic, porous, and injectable (EPI) meta-material ( Fig. 1) according to the design specifications derived from clinical criteria and in silico simulation (Fig. 2) . The EPI biomaterial displays a unique tri-phasic rheology: Yield stress enables facile manual injection, followed by rapid initial self-healing to prevent spreading. The reversible elastic softening transition then progressively recovers an elastic storage modulus of 2-3kPa, in line with that of the local soft tissue 12, 13 . That same softening transition enables tissue-matching across a wide range of applied forces.
In-vivo
After the design, synthesis, and extensive in vitro testing of our engineered metamaterial, we then investigated in vivo performance of the EPI biomaterial. With the ultimate goal of clinical implementation, we specifically examined minimally-invasive delivery, in situ shapeability, long-term 3D shape maintenance and tissue integration. For this, we manually injected EPI biomaterial into the subcutaneous space of CD1 mice and then shaped it by application of gentle external force (Fig. 4a ). We found that fluidization enabled facile delivery through a 20G catheter. Magnetic Resonance Imaging (MRI) confirmed that the material behaved as a well-defined, cohesive implant in the dermal space ( Fig. 4b ).
During a time window of about 20 minutes following bolus injection, the material could be re-shaped in situ to produce a new desired shape, retained spontaneously ( Fig. 4c, 4d , 4e, Video Supplementary 22 ). This indicates our success in engineering a shapeable material that provides substantial lifting capacity for 3D soft tissue reconstruction. For comparison we also injected a bolus of the hyaluronic acid dermal filler (Juvéderm Voluma®) but were unable to perform in situ shaping, since the material would spread rather than adopt a new shape.
After the shaping time window, the shape stabilized and excessive force was required to dislodge the mechanically interlocked particles. We assessed the long-term stability by attempting to reshape the 3D volume (by massaging) every day during the first week, and then once a week for the remainder of the 3 week follow-up. Despite this gentle mechanical challenge, the shape remained remarkably stable (Fig. 4e ).
On the time scale of hours to days, initial stabilization by mechanical self-healing is most likely relayed by irreversible biological processes such as fibrin coagulation 41 , and progressive tissue ingrowth (Fig. 4f, 21 days) . At 6 months ( Fig. 4g , not shaped), we indeed find most of the implant pore space colonized, with an onset of scaffold degradation. We then assessed bio-integration at the scale of 1 year in Fig. 4h and 4i (reaction mix diluted 2:1 with deionized water to enhance our chances to observe late biodegradation stages, not shaped). We find areas of advanced EPI biomaterial degradation at one year (stars in Fig. 4i ). A fibrovascular tissue (pink in Fig. 4h Taken together, our in vivo experimentation demonstrated that the unique rheological and morphological properties of the EPI biomaterial translated into a novel capacity to inject, shape, and stabilize customized 3D tissue volumes for tissue induction. Given the range of conditions driving a pathological loss of soft tissue volume, we propose that our new meta-material approach could have a major impact on clinical 3D tissue reconstruction.
Discussion
We present the design, synthesis, and testing of an in-vivo 3D shape tissue engineering material baed on meta-material physics. 23, 24 Numerical simulation allowed us to translate the unmet clinical need of a shapeable soft tissue implant 8, 11, 16 into a set of engineer-able mechanical and geometric parameters. With the elastic, porous, and injectable (EPI) biomaterial, we achieved desired shape-stable, softening, and yielding behaviors, along with substantial porosity and a tissue-matching mechanical response.
The result was excellent in-vivo injectability, shapeability, shape stabilization as well as long-term 3D tissue integration.
In this work we engineered and exploited the elastic softening transition to combine injectability with the full matching of adipose tissue rheology over a wide range of strains. Such an approach allows for a minimally-invasive filler with unprecedented in vivo 3D lifting 11 and shaping capacity. Strain softening is common in ductile materials (like plastics or metal alloys) but it is generally accompanied by large-scale plastic deformation 42 . On the contrary, reversible strain softening with negligible deformation is rare, but has been described previously in actin or cellulose hydrogels 26, 27 . Thought to be caused by a buckling of constituent fibers, this response allows the network to maintain rigidity at near static conditions but smoothly and reversibly respond to moderate forces by controlled deformation after softening 26 . Reversible strain softening in microgel suspensions has been conjectured 25, 43 , here we provide experimental proof.
Taught by the numerical simulation, the key to this achievement is the combination of porosity and irregular particle shape. Indeed, spherical cryogel particles are reported to display a low yield strain and complete absence of a softening regime 44 , while dermal fillers with irregular hyaluronic acid particles 40 have high yield strain 8 , but do not display reversible softening.
Our focus on geometrical design of the microstructure characterizes the EPI biomaterial as a mechanical meta-material 24 . Here we employed carboxymethylcellulose-based scaffold chemistry for its known biocompatibility 34 and obtained excellent biointegration up to 1 year. Nevertheless, our meta-material design suggests that other scaffold chemistries could be used to realize similar materials. Thus injectable, shapeable, porous materials could be applied to fields as diverse as bone engineering, wound repair, and regenerative organ engineering. By modulating the stiffness, degradation, and biological activity or cell delivery 14, 37 , we believe our approach is well suited for a wide range of customized tissue engineering applications beyond 3D soft tissue reconstruction.
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Online Methods
Simulation
The simulation was implemented as a custom Python library. It implements the physical interaction framework defined by Otsuki at al. 25 , corresponding to central viscoelastic interaction and tangential friction between spherical particles. To ensure exact rather than approximate conservation of angular momentum, we adjusted the expression of the torque resulting from frictional interaction (Supplementary 1, eq. S1-3).
To correctly evaluate stress tensors at large amplitudes, we implemented the stress tensor evaluation framework provided by Nicot et al. 29 . As unit testing ( Supplementary   4 ) revealed non-symmetric stress tensors in some cases, we re-evaluated the calculations by Nicot et al. 29 . We found a probable integration mistake regarding the inertia matrix for the contribution of unbalanced torques to the stress tensor (Supplementary 1). This directly concerns eq. 29 in ref. 29 , and as result also eq. 30-35 in ref. 29 ; we use a corrected version of eq. 34 in Nicot et al. 29 , supplied as eq. S1-24 in Supplementary 1. To avoid complete interpenetration of neighboring particles at large shear, we added a non-linear term to the repulsive elastic interaction. We ensured that in the small compression limit, we recover the linear repulsion law used by Otsuki et al. 25 (Supplementary 1, eq. S5b ).
Finally, we also implement the possibility of permanent crosslinks between neighboring spheres. The permanent crosslinks remain intact regardless of the geometrical separation of the spheres, generating attractive forces if the spheres are separated beyond touching distance. They also do not allow for frictional slippage. Additional mathematical details of the implementation are given in Supplementary 1 The simulations were run on the Baobab cluster of the University of Geneva.
Instructions on how to replicate our simulations and data analysis are provided in Supplementary 2.
Statistics
Statistical evaluation and graphing were done using the R-Cran free software, version 3.2.3 45 . Central tendency was reported by arithmetic mean values, and variability by indication of single standard deviations. For comparisons with 5 or less measurements per group, individual values were also graphed ( Fig. 3i, Fig. 4e ). Linear regression was used to assess continuous effects, and paired or unpaired, Student (t) tests were used to compare individual conditions, with P-values reported after Bonferroni multiple testing correction 46 For the statistical evaluation of the characteristic strains and stresses of the simulated elastic storage modulus and viscous loss modulus curves (G' and G'') as a function of the model parameters (Fig. 2G ) a bootstrapping approach was taken 48 . For a given set of model parameters, 5 subsets among the simulations carried out for the various strain amplitudes are drawn randomly with a 20% probability for a given simulation to be included. For each subset, slightly different estimations for characteristic stresses and strains as defined in Fig. 2f are thus obtained. By linear regression of these values against the physical parameter being varied, the P-values depicted in Fig. 2g are obtained after Bonferroni correction 46 . To reduce dependence of the P-value on the random draw, we averaged the underlying F-statistics over 500 bootstrapping runs 48 . 
Biomaterial synthesis
Cryogel scaffolds were synthesized as reported 37 , with minor modifications. Briefly, carboxymethyl cellulose (13.56 g), PIPES Buffer (6.30 g), adipic acid anhydride (486 mg) and NaOH pellets (1.20 g) was dissolved to a final volume of 1000 mL in deionized water and the solution filtered at 0.2 µm. This solution could be stored in a 4°C for up to a month prior to use in a fridge. Then EDC (2.70 g) was added. After mixing, the solution was filled into 35 mL plastic syringes. The syringes were closed with a syringe cap and then placed into a freezer set to -20 o C.
After 2 days the syringes were removed from the freezer and allowed to reach room temperature. The EPI biomaterial was obtained by forceful extrusion through a 22G
catheter. On a filter system, the biomaterial was washed with 10mM EDTA, followed by incubation with 2 M NaOH solution (2h), washing with physiological saline (3x). For invivo experiments the biomaterial was sterilized for 20 min at 121°C.
Microscopic imaging
Confocal images were captured on a confocal Zeiss LSM 700 driven by Zen 2010b Further details on the microscopes and lenses in the text.
For visualization and morphological quantification, the EPI biomaterial was stained with 5microgram/mL Rhodamine 6G hydrochloride ( Fig. 1 and 3a) or 4′,6-diamidino-2phenylindole (DAPI, by affinity to the final material) or 6-aminofluorescein (by inclusion of 10 micromolar aminofluorescein into the synthesis mixture 37 ), or DAPI and aminofluorescein ( Fig. 1 ). For the reference material, Sephacryl S200, auto-fluorescence images (excitation 353nm, emission 405nm and above) was used for visualization and quantification.
Scanning electron microscope SEM images were finally acquired with a Zeiss Merlin SEM, equipped with a Gemini II column and the ZeissSmartSEM acquisition software.
Pore size and pore fraction
After staining (for the EPI biomaterial) and confocal image acquisition, Fiji software 49 (ImageJ version 2.0.0-rc-44/1.50g) was used to visualize z-stack images, and to quantify pore size and fraction as well as particle size. For pore fraction quantification, images were acquired at a resolution so that several pores fit across the image, implying generally the use of a 10x objective for the EPI biomaterial vs. a 20x objective for the Rheological master curves represent the elastic modulus G' normalized to the plateau value at low stress 39 . They are obtained by normalizing G' curves with respect to the low-strain G0' plateau value 39 . We evaluate the low-strain limit G0' as the average of the G' values for the measurement points with low applied shear stress (τ<2Pa). We further take care to exclude points showing already an onset of softening or liquefaction by also imposing G''(τ)<0.1*G'(τ). We also normalize the applied stress τ to G0'. After visual verification that indeed all the different G' curves obtained at different polymer concentrations collapse onto a single master curve after normalization of both the G' and τ, we obtain the main master curve by averaging of the normalized curves, along with evaluation of the standard deviation. For the more horizontal part of the master curve (G'/G0'>0.5 for the Sephacryl S200 master curve, G'/G0'>0.1 for the EPI biomaterial) we perform vertical averaging of the G'/G0' associated with a given interval of applied stress τ, whereas for the steepest part of the master curves, we rather average the τ associated with a given interval of G'/G0' values.
Uniaxial compression and injectability testing
We 
Animal experiments
sacrificed by intraperitoneal injection of sodium pentobarbital (150mg/kg), followed by transcardial perfusion with 4% paraformaldehyde in PBS. Harvested samples were further immersed for 24 hours in 4% paraformaldehyde at 4°C, washed 3x with PBS and embedded in paraffin following routine procedures. 4 µm slices were stained with hematoxylin/eosin in an automated slide processor (Prisma special stainer, Tissue-Tek;
Glas G2 coverslipper from Sakura). During measurements, each adult mouse was anesthetized with 1.5-2% isoflurane in mixture of air and O2 (50/50%) and subsequently placed supine within an adapted holder. Body temperature was maintained at 37°C using a thermoregulated water circuit. Monitoring respiration with a respiration cushion was used for triggering during all acquisitions.
Magnetic resonance imaging
Spin echo intensity images were acquired with a repetition time of 1.5s and echo times at 14ms and again at 25ms (the overall intensity of this second echo is used for the images shown). The acquisition matrix was 96×192 pixels for a field of view of 15×25 mm, with 46 slices spaced by 0.05 mm. The acquisition time was on average 12min, with minor differences due to respiratory gating.
Replication
Unless explicitly stated otherwise, replicated experiments were performed on distinctly prepared biomaterial samples. We further used two 2 separate 1L synthesis batches.
Thus the samples contain variability associated with sample preparation, and to some extent chemical synthesis. We used however identical reagent stocks, and so cannot guard against lot-to-lot variation of the chemicals obtained commercially.
Supplementary 10 further compares rheological characterization in two distinct geometries.
